These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34902646)

  • 1. Synthesis and structure activity relationship of the first class of LXR inverse agonists.
    Elgendy B; Griffett K; Hegazy L; Di Fruscia P; Sample K; Schoepke E; Kamenecka TM; Burris TP
    Bioorg Chem; 2022 Feb; 119():105540. PubMed ID: 34902646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
    Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
    Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A liver-selective LXR inverse agonist that suppresses hepatic steatosis.
    Griffett K; Solt LA; El-Gendy Bel-D; Kamenecka TM; Burris TP
    ACS Chem Biol; 2013 Mar; 8(3):559-67. PubMed ID: 23237488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease.
    Griffett K; Burris TP
    Biochem Biophys Res Commun; 2016 Oct; 479(3):424-428. PubMed ID: 27680310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists.
    Namba N; Noguchi-Yachide T; Matsumoto Y; Hashimoto Y; Fujii S
    Bioorg Med Chem; 2022 Jul; 66():116792. PubMed ID: 35576658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
    Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
    Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis.
    Huang P; Kaluba B; Jiang XL; Chang S; Tang XF; Mao LF; Zhang ZP; Huang FZ
    Biomed Res Int; 2018; 2018():8071093. PubMed ID: 29670908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestenoic acid analogues as inverse agonists of the liver X receptors.
    Alvarez LD; Dansey MV; Ogara MF; Peña CI; Houtman R; Veleiro AS; Pecci A; Burton G
    J Steroid Biochem Mol Biol; 2020 May; 199():105585. PubMed ID: 31931135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold.
    Goher SS; Griffett K; Hegazy L; Elagawany M; Arief MMH; Avdagic A; Banerjee S; Burris TP; Elgendy B
    Bioorg Med Chem Lett; 2019 Feb; 29(3):449-453. PubMed ID: 30587446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.
    Zhang-Gandhi CX; Drew PD
    J Neuroimmunol; 2007 Feb; 183(1-2):50-9. PubMed ID: 17175031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases.
    Yu S; Li S; Henke A; Muse ED; Cheng B; Welzel G; Chatterjee AK; Wang D; Roland J; Glass CK; Tremblay M
    FASEB J; 2016 Jul; 30(7):2570-9. PubMed ID: 27025962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of a series of liver X receptor antagonists.
    Jiao X; Kopecky DJ; Fisher B; Piper DE; Labelle M; McKendry S; Harrison M; Jones S; Jaen J; Shiau AK; Escaron P; Danao J; Chai A; Coward P; Kayser F
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5966-70. PubMed ID: 22901900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors.
    Chen Z; Chen H; Zhang Z; Ding P; Yan X; Li Y; Zhang S; Gu Q; Zhou H; Xu J
    Eur J Med Chem; 2020 Nov; 206():112793. PubMed ID: 32961480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity.
    Gong H; Weinstein DS; Lu Z; Duan JJ; Stachura S; Haque L; Karmakar A; Hemagiri H; Raut DK; Gupta AK; Khan J; Camac D; Sack JS; Pudzianowski A; Wu DR; Yarde M; Shen DR; Borowski V; Xie JH; Sun H; D'Arienzo C; Dabros M; Galella MA; Wang F; Weigelt CA; Zhao Q; Foster W; Somerville JE; Salter-Cid LM; Barrish JC; Carter PH; Dhar TGM
    Bioorg Med Chem Lett; 2018 Jan; 28(2):85-93. PubMed ID: 29233651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.